Protein detail

AT2B3

Plasma membrane calcium-transporting ATPase 3 (PMCA3) (EC 7.2.2.10) (Plasma membrane calcium ATPase isoform 3) (Plasma membrane calcium pump isoform 3)

Protein symbol
AT2B3
UniProt ID
EVMP score
0.50
Frequency
1
Transmembrane count
10
Protein classification
Cancer-related genesDisease related genesEnzymesFDA approved drug targetsHuman disease related genesMetabolic proteinsPlasma proteinsPredicted intracellular proteinsPredicted membrane proteinsTransporters
EVMP score: annotation confidence score.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40
Basic Information
Protein Names
Plasma membrane calcium-transporting ATPase 3 (PMCA3) (EC 7.2.2.10) (Plasma membrane calcium ATPase isoform 3) (Plasma membrane calcium pump isoform 3)
Protein Class
Cancer-related genesDisease related genesEnzymesFDA approved drug targetsHuman disease related genesMetabolic proteinsPlasma proteinsPredicted intracellular proteinsPredicted membrane proteinsTransporters
Protein Function
  • Predicted intracellular proteins
  • Enzymes
  • ENZYME proteins
  • Transporters:Primary Active Transporters
  • Cancer-related genes
  • Disease related genes
  • FDA approved drug targets:Small molecule drugs
  • Human disease related genes:Endocrine and metabolic diseases:Adrenal gland diseases
Transmembrane
98..118; Helical; 156..176; Helical; 365..384; Helical; 418..435; Helical; 850..869; Helical; 880..900; Helical; 921..943; Helical; 962..983; Helical; 1003..1024; Helical; 1035..1056; Helical
Transmembrane Count
10
Entrez Gene Symbol
Gene Synonym
CFAP39CLA2PMCA3SCAX1
Gene Description
ATPase plasma membrane Ca2+ transporting 3
Chromosome
X
Position
153517642-153582939
Frequency
1
EVMP Score
0.50
Fluorescence & Localization
Function & Pathway
Protein Function
  • Predicted intracellular proteins
  • Enzymes
  • ENZYME proteins
  • Transporters:Primary Active Transporters
  • Cancer-related genes
  • Disease related genes
  • FDA approved drug targets:Small molecule drugs
  • Human disease related genes:Endocrine and metabolic diseases:Adrenal gland diseases
Mediation Categories
Clinical-translation mediationFusion and delivery mediationImmune mediationMetabolism mediation
Relations & Evidence

Enzyme-Mediated Modification

0 records.

Ligand-Receptor Signaling

20 records.

CategoryParentDatabaseTransmitterReceiverSecretedPlasma Membrane (Transmembrane)Plasma Membrane (Peripheral)
transmembranetransmembraneUniProt_keywordNoNoNoNoNo
transmembranetransmembraneLOCATENoNoNoNoNo
transmembranetransmembraneRamilowski_locationNoNoNoNoNo
transmembranetransmembraneOmniPathNoNoNoNoNo
plasma_membraneplasma_membraneUniProt_locationNoNoNoNoNo
plasma_membraneplasma_membraneOmniPathNoNoNoNoNo
cell_surfacecell_surfaceSurfaceomeNoNoNoNoNo
cell_surfacecell_surfaceOmniPathNoNoNoNoNo
receptorreceptorscConnectNoYesNoNoNo
transmembranetransmembrane_predictedPhobiusNoNoNoNoNo
Page 2 of 2Previous

Regulatory Interaction Network

0 records.

Protein Complex Composition

1 record.

Component NameComponent Gene SymbolsComponent UniProt IDStoichiometryDatabaseDatabase IDsReferences
ATP2B3HSD17B6O14756Q167200:0hu.MAP

Isolation & Detection Technology

1 record.

EV Isolation MethodDetection MethodNumber of ReferencesReferences
Differential UltracentrifugationUltrafiltration / Tangential Flow FiltrationMass spectrometry132795414
Sequence, Structure & Domains

Sequences

Length
1,220
Mass
134,197
Sequence
MGDMANSSIEFHPKPQQQRDVPQAGGFGCTLAELRTLMELRGAEALQKIEEAYGDVSGLCRRLKTSPTEGLADNTNDLEKRRQIYGQNFIPPKQPKTFLQLVWEALQDVTLIILEVAAIVSLGLSFYAPPGEESEACGNVSGGAEDEGEAEAGWIEGAAILLSVICVVLVTAFNDWSKEKQFRGLQSRIEQEQKFTVIRNGQLLQVPVAALVVGDIAQVKYGDLLPADGVLIQANDLKIDESSLTGESDHVRKSADKDPMLLSGTHVMEGSGRMVVTAVGVNSQTGIIFTLLGAGGEEEEKKDKKGKQQDGAMESSQTKAKKQDGAVAMEMQPLKSAEGGEMEEREKKKANAPKKEKSVLQGKLTKLAVQIGKAGLVMSAITVIILVLYFVIETFVVEGRTWLAECTPVYVQYFVKFFIIGVTVLVVAVPEGLPLAVTISLAYSVKKMMKDNNLVRHLDACETMGNATAICSDKTGTLTTNRMTVVQSYLGDTHYKEIPAPSALTPKILDLLVHAISINSAYTTKILPPEKEGALPRQVGNKTECALLGFVLDLKRDFQPVREQIPEDKLYKVYTFNSVRKSMSTVIRMPDGGFRLFSKGASEILLKKCTNILNSNGELRGFRPRDRDDMVRKIIEPMACDGLRTICIAYRDFSAGQEPDWDNENEVVGDLTCIAVVGIEDPVRPEVPEAIRKCQRAGITVRMVTGDNINTARAIAAKCGIIQPGEDFLCLEGKEFNRRIRNEKGEIEQERLDKVWPKLRVLARSSPTDKHTLVKGIIDSTTGEQRQVVAVTGDGTNDGPALKKADVGFAMGIAGTDVAKEASDIILTDDNFTSIVKAVMWGRNVYDSISKFLQFQLTVNVVAVIVAFTGACITQDSPLKAVQMLWVNLIMDTFASLALATEPPTESLLLRKPYGRDKPLISRTMMKNILGHAVYQLAIIFTLLFVGELFFDIDSGRNAPLHSPPSEHYTIIFNTFVMMQLFNEINARKIHGERNVFDGIFSNPIFCTIVLGTFGIQIVIVQFGGKPFSCSPLSTEQWLWCLFVGVGELVWGQVIATIPTSQLKCLKEAGHGPGKDEMTDEELAEGEEEIDHAERELRRGQILWFRGLNRIQTQIRVVKAFRSSLYEGLEKPESKTSIHNFMATPEFLINDYTHNIPLIDDTDVDENEERLRAPPPPSPNQNNNAIDSGIYLTTHVTKSATSSVFSSSPGSPLHSVETSL
Alternative Products
Event=Alternative splicing; Named isoforms=8; Comment=There is a combination of two alternatively spliced domains at N-terminal site A (X and Z) and at C-terminal site C (A, B, E and G). The splice sites have mostly been studied independently. Full isoforms so far detected are isoform XA and isoform XB. Experimental confirmation may be lacking for some isoforms.; Name=XB; Synonyms=AIICI; IsoId=Q16720-1; Sequence=Displayed; Name=XA; Synonyms=AIICII; IsoId=Q16720-2; Sequence=VSP_000393; Name=ZA; Synonyms=AICII; IsoId=Q16720-3; Sequence=VSP_000392, VSP_000393; Name=ZB; Synonyms=AICI; IsoId=Q16720-4; Sequence=VSP_000392; Name=XE; Synonyms=AIICV; IsoId=Q16720-5; Sequence=VSP_000394; Name=ZE; Synonyms=AICV; IsoId=Q16720-6; Sequence=VSP_000392, VSP_000394; Name=XG; Synonyms=AIICVII; IsoId=Q16720-7; Sequence=VSP_000395; Name=ZG; Synonyms=AICVII; IsoId=Q16720-8; Sequence=VSP_000392, VSP_000395
Alternative Sequence
306..319; Missing (in isoform ZA, isoform ZB, isoform ZE and isoform ZG); 1115..1220; IRVVKAFRSSLYEGLEKPESKTSIHNFMATPEFLINDYTHNIPLIDDTDVDENEERLRAPPPPSPNQNNNAIDSGIYLTTHVTKSATSSVFSSSPGSPLHSVETSL -> MEVVSTFKRSGSVQGAVRRRSSVLSQLHDVTNLSTPTHAILSAANPTSAAGNPGGESVP (in isoform XA and isoform ZA); 1115..1220; IRVVKAFRSSLYEGLEKPESKTSIHNFMATPEFLINDYTHNIPLIDDTDVDENEERLRAPPPPSPNQNNNAIDSGIYLTTHVTKSATSSVFSSSPGSPLHSVETSL -> MEVVSTFKRSGSVQGAVRRRSSVLSQLHDVTNLSTPTHAILSAANPTSAAGSES (in isoform XE and isoform ZE); 1115..1220; IRVVKAFRSSLYEGLEKPESKTSIHNFMATPEFLINDYTHNIPLIDDTDVDENEERLRAPPPPSPNQNNNAIDSGIYLTTHVTKSATSSVFSSSPGSPLHSVETSL -> VCWDGKKMLRTTEVG (in isoform XG and isoform ZG)

3D Structural Models

Domain & Motif Annotations

Compositional Bias
1..20; Polar residues; 299..308; Basic and acidic residues; 342..355; Basic and acidic residues
Region
1..23; Disordered; 298..355; Disordered; 1097..1114; Calmodulin-binding subdomain A; 1115..1124; Calmodulin-binding subdomain B; 1166..1186; Disordered
Protein Families
  • Cation transport ATPase (P-type) (TC 3.A.3) family
  • Type IIB subfamily
Sequence Similarities
Belongs to the cation transport ATPase (P-type) (TC 3.A.3) family. Type IIB subfamily.
Clinical Relevance
Disease Involvement
Cancer-related genesDisease variantFDA approved drug targetsNeurodegeneration
Drug Targets
FDA approved drug targets
Interaction Protein
ENSG00000070961
Interaction Count
1
Interaction Dataset
biogrid_opencell